Miriam Valenzuela-Cardenas

Also affiliated with University of California, Los Angeles, University of New Mexico, Los Angeles Medical Center

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection”.

Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection

Molecular Therapy — Oncolytics(2023)10.1016/j.omto.2023.08.014

N/A

0DataRank · unranked

7 citations

Mee Y. Bartee, Miriam Valenzuela-Cardenas, Eric Bartee, Raquela J. Thomas

IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200866

N/A

0DataRank · unranked

4 citations

Carrie Fisher, Mee Y. Bartee, Eric Bartee, Miriam Valenzuela-Cardenas